drugset / Trial / NCT02052011

Ranolazine and Microvascular Angina by PET in the Emergency Department

NCT02052011

Phase 4 Completed 31 enrolled Yale University Gilead Sciences · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of Ranolazine for the treatment chest pain from disease of small vessels of the heart also known as 'microvascular angina'.

Timeline

Start
2014-04
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ranolazine Small molecule 1000 mg